Use Opal to monitor COVID-19 symptoms
The Opal Health Informatics Group was pleased to partner with the research team of Dr. Bertrand Lebouché to conduct the Opal-COVID study. This study is now complete.
Research team of Dr. Bertrand Lebouché
(+1) 438 822-2004
opalcovid.study@gmail.com
Can I participate?
-
You can participate in the Opal-COVID study if:
- Your COVID-19 test result done at the MUHC is positive.
- You are prescribed self-isolation at home.
- You have an iOS or Android cell phone.
- You have a RAMQ medicare card.
Why participate?
By participating in the Opal-COVID study, you will be able to:
Self-monitor
Self-monitor your symptoms with an
oximeter (and a thermometer if
needed) provided by the research
team and report them via Opal.
Tele-consult
Tele-consult with a healthcare
professional if your symptoms
worsen.
Stay informed
Learn more about COVID-19
and receive counselling.
Opal will help you to reduce your risk and stay in touch with your healthcare team while you are at home.
About the Opal-COVID Study
The Opal app is still in pilot phase and the Opal-COVID study is designed to evaluate its use in monitoring COVID-19 symptoms remotely.
Partners and Supporters of the Opal-COVID Study
